ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (&gt;32MM)

Yuki Ishibashi; Yoshinobu Onuma; Sjoerd T. Nauta; Roberto Diletti; Αντώνιος Καρανάσος; Takashi Muramatsu; Evelyn Regar; Nicolas M. Van Mieghem; Peter de Jaegere; Patrick W. Serruys; Felix Zijlstra; Robert van Geuns

doi:10.1016/s0735-1097(14)61891-x

Related publications

Article2011

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

Roberto Diletti, Yoshinobu Onuma, Vasim Farooq, Josep Gómez‐Lara, Salvatore Brugaletta, Robert‐Jan van Geuns, Evelyn Regar, Bernard De Bruyne, Dariusz Dudek, Leif Thuesen, Bernard Chevalier, Dougal McClean, Stephan Windecker, Robert Whitbourne, Li Dong, Susan Veldhof, Richard Rapoza, Krishnakutty Sudhir, Héctor M. García‐García, John A. Ormiston, Patrick W. Serruys

Journal of the American College of Cardiology

Article2013

TCT-429 Short- and intermediate- term clinical outcomes after implantation of everolimus-eluting bioresorbable scaffold in complex lesions : a prospective single-arm study - ABSORB Expand trial

Robert J. Van Geuns, Peter de Jaegere, Roberto Diletti, Αντώνιος Καρανάσος, Takashi Muramatsu, Sjoerd T. Nauta, Yoshinobu Onuma, Evelyn Regar, Carl Schultz, Patrick W. Serruys, Nicolas M. Van Mieghem, Felix Zijlstra

Journal of the American College of Cardiology

Article2012

TCT-40 Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND Single-arm Trial

Takashi Muramatsu, Yoshinobu Onuma, Héctor M. García‐García, Vasim Farooq, Marie-Angèle Morel, Cécile Dorange, Susan Veldhof, Alexandre Abizaid, Patrick W. Serruys

Journal of the American College of Cardiology

Article2020

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

Yoshinobu Onuma, Bernard Chevalier, Masafumi Ono, Ángel Cequier, Dariusz Dudek, Michael Haude, Didier Carrié, Manel Sabaté, Stephan Windecker, Richard Rapoza, Nick E.J. West, Sebastian Reith, Manuel de Sousa Almeida, Gianluca Campo, Andrés Íñiguez, Patrick W. Serruys

EuroIntervention

Article2018

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

Patrick W. Serruys, Bernard Chevalier

Journal of the American College of Cardiology

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)

Abstract

Discussion(0)

Related publications

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

TCT-429 Short- and intermediate- term clinical outcomes after implantation of everolimus-eluting bioresorbable scaffold in complex lesions : a prospective single-arm study - ABSORB Expand trial

TCT-40 Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND Single-arm Trial

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (&gt;32MM)

Abstract

Discussion(0)

Related publications

SIX MONTH CLINICAL OUTCOMES FOLLOWING THE IMPLANTATION OF THE BIORESORBABLE EVEROLIMUS ELUTING VASCULAR SCAFFOLD IN VESSELS SMALLER OR LARGER THAN 2.5 MM

TCT-429 Short- and intermediate- term clinical outcomes after implantation of everolimus-eluting bioresorbable scaffold in complex lesions : a prospective single-arm study - ABSORB Expand trial

TCT-40 Incidence and Acute Clinical Outcomes of Small Side Branch Occlusion After Implantation of Everolimus-eluting Bioresorbable Vascular Scaffold in the ABSORB-EXTEND Single-arm Trial

Bioresorbable scaffolds versus everolimus-eluting metallic stents: five-year clinical outcomes of the randomised ABSORB II trial

TCT-62 Five-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Scaffolds: Results From the Randomized ABSORB II Trial

ACUTE ANGIOGRAPHIC AND SIX-MONTH CLINICAL OUTCOMES AFTER IMPLANTATION OF EVEROLIMUS-ELUTING BIORESORBABLE SCAFFOLDS IN LONG LESIONS (>32MM)